Sanofi, a global and diversified healthcare leader, reports results for the second quarter of 2013. CEO Chris Viehbacher comments on Q2 results and outlook.
Watch the video interview here:
Topics covered in the interview include:- Q2 2013 Results - FY 2013 Guidance - Capital Allocation - Diabetes - Vaccines - Genzyme - Animal Health - Emerging Markets - R&D Pipeline - Recent appointments About Sanofi Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Company website: www.sanofi.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts